Venture Capital Tracker is a free research layer for startup funding, venture capital firms, investor discovery, and source-backed market coverage.

Coverage snapshot

Know what’s in the dataset.

A growing research layer across funds, companies, and source-backed venture coverage.

832

VC firms

Profiles with stage, focus, and contact links.

2,074

Startups

Companies appearing in our funding coverage.

6

Latest signals

Fund closes and rounds in the investment feed.

1,456

Research articles

Analysis, explainers, and market roundups.

Deal flow

Latest funding & fund-close signals

A date-first view of the newest entries in the Venture Capital Tracker feed. Open each item for the full context and source trail.

View full feed
Funding round Nov 9

Nominal announces $240M Series C at $3B valuation led by Lightspeed and Insight

Nominal announced a $240M Series C on November 9, 2026, led by Lightspeed and co-led by Insight Partners at a company-stated $3B valuation. The round is distinct from its $75M June 2025 Series B and $80M March 2026 extension; U.S. Air Force STRATFI funding is not equity. Nominal Analyst remains in preview and revenue is undisclosed.

Funding round Nov 9

Sanyou Bio announces Series C of under approximately $15M, funded by Zero2IPO Industry Investment

November 9, 2026 issuer announcement: Sanyou Bio completed an amount-qualified Series C exclusively financed by Zero2IPO Industry Investment, managed by Zero2IPO Group. At the November 9 ECB rates, the reported ceiling converts to less than approximately $15M; the exact round sum and legal close date are not disclosed. Company-reported cumulative financing below about $45M is NOT new Series C proceeds.

Funding round Nov 9

geniosAI discloses $19.1M combined seed and Series A, with FactSet leading Series A

On Nov 9 2026 geniosAI disclosed $19.1M in combined prior seed and Series A financing. FactSet led Series A, with Zoom and General Catalyst among investors. Individual tranches, dates, valuation and amount NEWLY closed Nov 9 are undisclosed. Record $19.1M once as combined disclosed capital, not a $19.1M standalone Series A.

Funding round Nov 9

SRTD Biotech completes €31.5M seed for cell-selective RNA therapeutics

Jülich-based SRTD Biotech announced the completed €31.5M seed Nov 9, 2026, led by Mérieux Equity Partners with NRW.BANK and Boehringer Ingelheim Venture Fund co-leading, plus Lilly Ventures, HTGF and Anobis. NRW.BANK disclosed €7M included in the round. Funds preclinical seRNA studies toward IND; valuation undisclosed.

Funding round Nov 9

Spines secures separate $35M non-dilutive financing facility from Twelve

November 9, 2026 issuer announcement: Twelve provides a $35M non-dilutive growth financing facility to Spines, separate from a $29M Series A-1 equity round. Facility drawdown, pricing, repayment, collateral and conditions are undisclosed; capacity is not necessarily cash received.

Funding round Nov 9

Spines announces $29M Series A-1 equity led by Zeev Ventures within mixed $64M package

Spines' November 9 company-issued release separates $29M Series A-1 equity led by Zeev Ventures from a separate $35M non-dilutive growth-financing facility provided by Twelve. The $64M total is mixed financing, not a $64M equity round. Valuation and legal completion date not disclosed.

Go deeper

Research the market your way.

Use the structured pages when you need a shortlist, a company read, or a plain-English answer about how venture capital works.

Built from structured profiles and source-backed editorial coverage. How we curate the data